Cargando…
Fecal microbiota transplantation – where are we?
Autores principales: | Mikolašević, Ivana, Hauser, Goran, Abram, Maja, Filipec, Tajana, Kanižaj, Radić, Marija, Krznarić, Irena, Zrnić |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Croatian Medical Schools
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7976890/ https://www.ncbi.nlm.nih.gov/pubmed/33660961 http://dx.doi.org/10.3325/cmj.2021.62.52 |
Ejemplares similares
-
Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?
por: Mikolasevic, Ivana, et al.
Publicado: (2020) -
Assessment of Steatosis and Fibrosis in Liver Transplant Recipients Using Controlled Attenuation Parameter and Liver Stiffness Measurements
por: Mikolasevic, Ivana, et al.
Publicado: (2021) -
Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma – where do we stand?
por: Mikolašević, Ivana, et al.
Publicado: (2018) -
Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
por: Mikolasevic, Ivana, et al.
Publicado: (2018) -
Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand?
por: Mikolasevic, Ivana, et al.
Publicado: (2021)